Explore Products
Primary Cells

Human Ovarian Cancer Peripheral Blood Mononuclear Cells

  • 253
Included Diagnoses: Serous and other carcinomas of the ovary, Endometrial adenocarcinoma (including all subtypes) and Squamous Cell Carcinoma (including all subtypes),Neuroendocrine tumors of the ovary, Brenner Tumors.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC4363

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Ovarian Cancer

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human Ovarian Cancer Peripheral Blood Mononuclear Cells are immune cells isolated from the peripheral blood of ovarian cancer patients, primarily comprising lymphocytes (T cells, B cells, NK cells) and monocytes. These cells play a critical role in antitumor immune responses, including antigen presentation (monocytes/macrophages), cytotoxic activity (NK and CD8+ T cells), and antibody production (B cells). In ovarian cancer, PBMCs are often functionally impaired due to tumor-mediated immunosuppression, characterized by increased regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and exhausted T cell phenotypes, which contribute to immune evasion and disease progression].

View Product Image

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • Human Ovarian Cancer Peripheral Blood Mononuclear Cells can be used to analyze the immune escape mechanism of ovarian cancer, such as detecting the increase in the proportion of regulatory T cells (Tregs) and the expansion of myeloid-derived suppressor cells (MDSCs). These cells can also be used to screen biomarkers that predict the efficacy of immune checkpoint inhibitors and evaluate the feasibility of adoptive cell therapies such as CAR-T.

Inquiring Human Ovarian Cancer Peripheral Blood Mononuclear Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button